Pharmafile Logo
Pharmafocus logo
Advanced Search

Research and Development

Showing 15 posts of 9607 posts found.

Collaborative cancer drug project targets research efficiency

May 5, 2010 Research and Development Animal testing, Animal tests, Cancer, biomarkers, clinical drug development

A new pharma-academia project being managed by the University of Dundee is setting its sights on improving the effectiveness of …
News

BMS on tenterhooks over belatacept future

May 4, 2010 Research and Development BMS, belatacept

Bristol-Myers Squibb has been kept on tenterhooks by US regulator the FDA over the future of its investigational kidney transplant …
News

Chiltern Wins Award at the Inaugural US Pharma Awards Ceremony

May 4, 2010 Research and Development

Glenn Kerkhof, Chiltern CEO, congratulated Kim Todd, Chiltern’s Silver Medal Award Winner in the category of experienced Clinical Research Associate/Site …
News
Press release

Contract research news in brief

May 4, 2010 Research and Development Corealis, Norwich Pharma, PPD, PRA, biofocus

Our round-up of developments in the contract research sector includes a new $41m contract for BioFocus, new locations for PPD, …
News

Evotec wins grant to advance H3 receptor antagonist

May 4, 2010 Research and Development CNS, Evotec, MS

Evotec is to receive funding of up to 1.5 million euros from a German government fund to advance its H3 …
News
Frazier

Merck separates president role, appoints Kenneth Frazier

April 30, 2010 Manufacturing and Production, Research and Development, Sales and Marketing Merck & Co, appointment, manufacturing and production, research and development, sales and marketing

Merck & Co has partially split the joint roles of chairman, chief executive and president currently held by Richard Clark, …
Appointment

Victoza claims head-to-head victory over Januvia

April 29, 2010 Research and Development, Sales and Marketing Novo, Novo Nordisk, Victoza

Novo Nordisk says its diabetes treatment showed “significant” benefits over Merck’s rival Januvia in a head-to-head trial. Results published in …
News

US pharma execs join Algeta board

April 29, 2010 Research and Development Algeta, appointment, research and development

Oslo-based oncology company Algeta has added Judith Hemberger and Kapil Dhingra to its board of directors. Judith Hemberger has more …
Appointment

RNA Interference using nanoparticles hits target in human patients

April 29, 2010 Research and Development SiRNA, nanoparticles, rnai

US researchers have shown that a targeted nanoparticle can penetrate cancer cells in order to deliver small interfering RNAs (siRNAs), …
News

Charles River to buy WuXi for $1.6bn

April 27, 2010 Research and Development Charles River, Charles River Laboratories, WuXi, contract research

Contract research and laboratory supplies giant Charles River has said it intends to purchase Chinese counterpart WuXi PharmaTech in a …
News

Recovery signs, but outsourcing gets more competitive

April 26, 2010 Manufacturing and Production, Research and Development Interphex, contract manufacturing, contract research, contract research organisation

The first green shoots of  recovery in the global economy – assuming of course they are not going to be …
News

Elan looks again at hiving off drug delivery unit EDT

April 22, 2010 Research and Development, Sales and Marketing Elan

Irish drugmaker Elan says it is once again considering spinning out its drug delivery division, Elan Drug Technology, after abandoning …
News
BayerJogReinhardt

Bayer lures Novartis’ Reinhardt for top healthcare post

April 22, 2010 Research and Development, Sales and Marketing Bayer, appointment, research and development, sales and marketing

German pharma company Bayer has ended its search for someone to replace healthcare chief executive Arthur Higgins, appointing Dr Jörg …
Appointment

Astellas eyes oncology growth

April 21, 2010 Research and Development, Sales and Marketing Astellas, Astellas Pharma Europe

Astellas Pharma Europe has set its sights on the oncology market, earmarking the therapy area as its latest “franchise focus” …
News

GSK’s Arzerra conditionally approved in Europe

April 20, 2010 Research and Development, Sales and Marketing Arzerra, GSK, leukaemia

GlaxoSmithKline’s orphan cancer treatment Arzerra has been given conditional marketing authorisation in the European Union. Arzerra (ofatumumab) can be used …
News
The Gateway to Local Adoption Series

Latest content

Secarna appoints Jens Holstein and Richard Mark Engelhard to new Advisory Board

March 25, 2026

Roche adds 2,176 NVIDIA Blackwell GPUs to its hybrid-cloud AI factory

March 25, 2026

ReproNovo appoints Mark Altmeyer as Chairman of the Board

March 24, 2026

EndoCyclic New Drug application approved by US FDA for endometriosis treatment

March 24, 2026

Mestag Therapeutics appoints Lindsey Rolfe as Chief Medical Officer and Pascal Merchiers as Chief Development Officer

March 23, 2026